ACTG1
Actin, cytoplasmic 2
Also known as: ACTG, ACTG_HUMAN, DFNA20, DFNA26
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P63261
- Gene
- ACTG1
- Ensembl
- ENSG00000184009
- Chromosome
- 17
- Canonical length
- 375 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
Actins are highly conserved proteins that are involved in various types of cell motility and in maintenance of the cytoskeleton. Three main groups of actin isoforms have been identified in vertebrate animals: alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. Actin gamma 1, encoded by this gene, is a cytoplasmic actin found in all cell types. Mutations in this gene are associated with DFNA20/26, a subtype of autosomal dominant non-syndromic sensorineural progressive hearing loss and also with Baraitser-Winter syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
375 residues, UniProt reviewed canonical sequence.
>P63261|ACTG1
1 MEEEIAALVI DNGSGMCKAG FAGDDAPRAV FPSIVGRPRH QGVMVGMGQK DSYVGDEAQS
61 KRGILTLKYP IEHGIVTNWD DMEKIWHHTF YNELRVAPEE HPVLLTEAPL NPKANREKMT
121 QIMFETFNTP AMYVAIQAVL SLYASGRTTG IVMDSGDGVT HTVPIYEGYA LPHAILRLDL
181 AGRDLTDYLM KILTERGYSF TTTAEREIVR DIKEKLCYVA LDFEQEMATA ASSSSLEKSY
241 ELPDGQVITI GNERFRCPEA LFQPSFLGME SCGIHETTFN SIMKCDVDIR KDLYANTVLS
301 GGTTMYPGIA DRMQKEITAL APSTMKIKII APPERKYSVW IGGSILASLS TFQQMWISKQ
361 EYDESGPSIV HRKCFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACTG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 2,381 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 2,381 nTPM
- ovary: 2,001 nTPM
- pancreas: 1,883 nTPM
- blood vessel: 1,792 nTPM
- lymph node: 1,587 nTPM
- adipose tissue: 1,536 nTPM
Single-cell type
- esophageal apical cells: 15,149 nCPM
- esophageal suprabasal cells: 7,218 nCPM
- megakaryocytes: 5,706 nCPM
- extravillous trophoblasts: 5,613 nCPM
- pancreatic acinar cells: 5,232 nCPM
- suprabasal keratinocytes: 5,030 nCPM
Immune cell
- total PBMC: 5,302 nTPM
- basophil: 4,260 nTPM
- eosinophil: 3,021 nTPM
- myeloid DC: 3,018 nTPM
- T-reg: 2,989 nTPM
- non-classical monocyte: 2,954 nTPM
Brain region
- white matter: 1,100 nTPM
- hypothalamus: 1,037 nTPM
- medulla oblongata: 1,002 nTPM
- pons: 942 nTPM
- thalamus: 928 nTPM
- spinal cord: 858 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACTG1.
Disease | AllUniProt
Conditions ACTG1 is implicated in, by any mechanism.
- Deafness, autosomal dominant, 20 (DFNA20) MIM:604717
- Baraitser-Winter syndrome 2 (BRWS2) MIM:614583
Disease | GeneticClinVar
59 pathogenic / likely-pathogenic of 722 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal dominant nonsyndromic hearing loss 20
- Baraitser-winter syndrome 2
- Rare genetic deafness
- Inborn genetic diseases
- Lissencephaly
Disease | ImmuneIEDB
Conditions an epitope on ACTG1 was assayed in.
- rheumatoid arthritis B cell
- multiple sclerosis B cell
- allergic disease T cell
- onchocerciasis B cell
- autoimmune hepatitis B cell
- primary biliary cholangitis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0
- gnomAD missense Z
- 3.16
- DepMap mean gene effect
- -0.72
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- axonogenesis
- cell motility
- cellular response to type II interferon
- maintenance of blood-brain barrier
- morphogenesis of a polarized epithelium
- platelet aggregation
- positive regulation of cell migration
- positive regulation of gene expression
- positive regulation of wound healing
- protein localization to bicellular tight junction
- regulation of focal adhesion assembly
- regulation of stress fiber assembly
- regulation of synaptic vesicle endocytosis
- regulation of transepithelial transport
- sarcomere organization
- tight junction assembly
Molecular functions
- ATP binding
- hydrolase activity
- identical protein binding
- profilin binding
- protein kinase binding
- structural constituent of cytoskeleton
- structural constituent of postsynaptic actin cytoskeleton
- ubiquitin protein ligase binding
Cellular components
- actin cytoskeleton
- actin filament
- apical junction complex
- axon
- blood microparticle
- calyx of Held
- cell-cell junction
- cytoplasm
- cytoskeleton
- cytosol
- dense body
- extracellular exosome
- extracellular space
- filamentous actin
- focal adhesion
- membrane
- myofibril
- NuA4 histone acetyltransferase complex
- nucleus
- phagocytic vesicle
- plasma membrane
- Schaffer collateral - CA1 synapse
- synapse
- basal body patch
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACTG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACTG1 as an antibody target. Whether an autoantibody or antibody against ACTG1 could matter depends on whether native ACTG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACTG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACTG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...